Retour sur lavenir.net
   FAGRON 23.900 € (+0,63 %)     KBC 119.950 € (-0,21 %)     AGEAS 70.800 € (+0,07 %)     PROXIMUS 6.065 € (+2,28 %)     CENERGY 21.860 € (+0,18 %)     AZELIS GROUP 10.310 € (+0,68 %)     D'IETEREN GROUP 173.400 € (+0,29 %)     WDP 21.880 € (+0,27 %)     AB INBEV 70.060 € (+0,57 %)     CIE BOIS SAUVAGE 303.000 € (0,00 %)     ARGENX SE 767.000 € (+0,42 %)     DEME GROUP 165.000 € (-2,14 %)     ACKERMANS V.HAAREN 265.800 € (-0,82 %)     VGP 81.100 € (-0,37 %)     SYENSQO 66.600 € (+0,91 %)     SIPEF 90.500 € (0,00 %)     ELIA GROUP 136.700 € (0,00 %)     KINEPOLIS GROUP 36.750 € (+0,96 %)     MELEXIS 74.650 € (+3,25 %)     UMICORE 19.880 € (-0,90 %)     UCB 235.800 € (-0,55 %)     ASCENCIO 51.400 € (0,00 %)     IBA 17.160 € (+3,13 %)     ATENOR 1.630 € (+0,31 %)     MONTEA 67.300 € (+0,30 %)     CMB.TECH 13.760 € (+2,53 %)     BIOTALYS 3.000 € (-0,99 %)     ONTEX GROUP 2.210 € (0,00 %)     SOLVAY 26.100 € (+0,08 %)     TUBIZE-FIN 206.800 € (-0,86 %)     WERELDHAVE BELGIUM 53.000 € (+0,38 %)     XIOR 27.550 € (+0,55 %)     COLRUYT 37.160 € (+0,76 %)     BARCO 8.340 € (-0,30 %)     BPOST 1.602 € (+0,75 %)     AEDIFICA 69.300 € (+0,14 %)     SOFINA 226.600 € (+0,09 %)     NYRSTAR 0.062 € (+13,09 %)     GBL 77.550 € (-0,26 %)     EVS 27.100 € (-0,55 %)     BREDERODE 102.600 € (-0,77 %)     SHURGARD 26.300 € (0,00 %)     AGFA-GEVAERT 0.407 € (-1,21 %)     LOTUS BAKERIES 11 100.000 € (-1,07 %)     VIOHALCO 17.460 € (-1,91 %)     TESSENDERLO 20.450 € (+2,00 %)     EKOPAK 3.795 € (+3,13 %)     RETAIL ESTATES 68.500 € (+0,44 %)     KBC ANCORA 84.000 € (-0,36 %)     IMMOBEL 21.900 € (-0,45 %)     BEKAERT 40.000 € (+0,25 %)     TITAN S.A. 50.450 € (-0,20 %)     RECTICEL 11.400 € (-0,18 %)     HOME INVEST BE. 19.040 € (+0,53 %)     GIMV 44.825 € (+0,06 %)     BANIMMO A 2.900 € (0,00 %)     ONWARD MEDICAL 2.585 € (+2,99 %)     TINC 11.280 € (0,00 %)     HYLORIS 4.550 € (-2,15 %)     CARE PROPERTY INV. 12.600 € (0,00 %)  
   ASML HOLDING 1 540.800 € (-1,80 %)     ASR NEDERLAND 68.200 € (+0,24 %)     AKZO NOBEL 58.800 € (+2,44 %)     ING GROEP N.V. 28.345 € (-0,25 %)     PROSUS 39.275 € (-0,68 %)     ASM INTERNATIONAL 888.600 € (-2,39 %)     ABN AMRO BANK N.V. 37.980 € (-0,13 %)     V LANSCHOT KEMPEN 66.925 € (+3,68 %)     ARCELORMITTAL SA 57.460 € (-0,97 %)     APERAM 45.600 € (+1,33 %)     RANDSTAD NV 29.450 € (+3,01 %)     ADYEN 851.500 € (+0,58 %)     HEINEKEN 76.140 € (+0,45 %)     DSM FIRMENICH AG 84.160 € (+0,81 %)     AEGON 7.692 € (-0,10 %)     WOLTERS KLUWER 61.080 € (+0,96 %)     HEIJMANS KON 98.300 € (-1,80 %)     NN GROUP 76.220 € (+0,05 %)     AHOLD DEL 35.810 € (-0,28 %)     CVC CAPITAL 13.770 € (+2,08 %)     SHELL PLC 36.080 € (+0,99 %)     BE SEMICONDUCTOR 249.800 € (-2,15 %)     CSG 14.026 € (+3,12 %)     IMCD 85.620 € (+0,14 %)     ARCADIS 34.700 € (+0,52 %)     RELX 28.560 € (+0,56 %)     MAGNUM 16.314 € (+0,04 %)     ACOMO 22.950 € (+0,22 %)     SIGNIFY NV 16.320 € (-1,75 %)     PHARMING GROUP 1.184 € (-1,50 %)     SBM OFFSHORE 31.740 € (+0,83 %)     EXOR NV 68.300 € (-0,36 %)     UMG 18.995 € (+0,45 %)     AALBERTS NV 39.000 € (-0,76 %)     ICADE 18.700 € (+0,32 %)     SCHNEIDER ELECTRIC 267.900 € (-0,65 %)     GTT 188.100 € (0,00 %)     OVH 14.600 € (+0,90 %)     MEXEDIA 3.625 € (-0,14 %)     ELIOR GROUP 2.014 € (+0,20 %)     2CRSI 28.800 € (-6,19 %)     THALES 220.900 € (-1,07 %)     AIR LIQUIDE 174.480 € (+0,10 %)     STEF 123.200 € (+0,16 %)     PERNOD RICARD 63.820 € (-0,59 %)     SAFRAN 331.500 € (-1,37 %)     CAPGEMINI 90.180 € (+1,37 %)     KERING 249.500 € (+0,40 %)     NEXANS 132.200 € (-1,34 %)     KLEPIERRE 36.360 € (+0,61 %)     LVMH 489.600 € (-0,06 %)     WORLDLINE 10.044 € (-1,76 %)     IMERYS 21.300 € (+0,76 %)     AIR FRANCE -KLM 12.985 € (-2,59 %)     SANOFI 76.900 € (+0,88 %)     DBV TECHNOLOGIES 2.860 € (+0,28 %)     STMICROELECTRONICS 61.090 € (-1,47 %)     MICHELIN 34.690 € (-0,52 %)     GL EVENTS 31.700 € (-0,94 %)     EXOSENS 57.100 € (-1,13 %)  
News Réglementées
24/04/2023 14:02

Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

The Vanguard Group, Inc. ( )
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc

24-Apr-2023 / 13:02 GMT/BST


FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

The Vanguard Group, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

20 April 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

  1. Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,122,099

4.50%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

5,122,099

4.50%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p ordinary

Purchase

100

37.66 GBP

1p ordinary

Purchase

324

37.67 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

none

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

24 April 2023

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière